The team monitors healthcare trends, policy context, reimbursement dynamics, and demand signals across relevant public markets.
Disciplined Public Healthcare Investing
ST Global Health invests in listed healthcare companies working at the intersection of innovation, access, and commercial execution. The firm focuses on healthcare businesses with the potential to expand quality care, improve efficiency, and participate in durable global demand.
Ami Kemppainen
MANAGING PARTNER
Ami Kemppainen is Managing Partner of ST Global Health. He is an investment manager and financial entrepreneur with experience creating and managing boutique public-equity strategies focused on emerging themes and global market change.
Prior to ST Global Health, Ami founded and managed the Evli Emerging Frontier Fund and built a public equities strategy for Global Health Funds. His background combines portfolio construction, healthcare investment research, and strategy development for mission-aligned investment platforms.
Ami holds a bachelor’s degree in business from Brigham Young University and an MBA from Harvard Business School.
Supported by Focused Research
Research Process
ST Global Health’s investment process is supported by research assistants who help monitor healthcare markets, organize company and sector research, and surface relevant developments for further review. Their work strengthens the firm’s ability to evaluate themes, track public-company activity, and maintain a disciplined research cadence.
Final investment decisions remain led by the firm’s investment leadership.
Healthcare Market Review
Company & Sector Research
Research support organizes company materials, sector developments, and commercial indicators for investment leadership review.
Investment Leadership Review
The firm’s investment leadership evaluates research inputs through a disciplined public-equity decision process.